Accuracy

High efficiency

Economic

Compatibility

Customizable

Technical Specification
Size (L x W x H) Doors Closed:610 x 532 x 812 mm
Doors Opened: 1225 x 532 x 812 mm
Weight 95KG (approx.)
Channel 8, 16, 24, 96 (under research)
Fluorescence Dye 6、8
Capillary Length 36 cm、50 cm
Sampling Method Auto-Sampling, Compatible with 96-well plate(x2) and 8-strip tubes.
Polymer-Injection Method Auto-Polymer Injection
Laser Solid-state semiconductor
Laser wave length 505 nm
Fluorescence Dye wave length > 520 nm
Temp. Accuracy ΔT≤0.2℃
Resolution Ratio 0.15 bp
Detection Capability Above 850 bp
Fluorescence Dye wavelength > 520 nm
Power 220±10% VAC，50±1 Hz; Single Phase: 10 A，2200 VA
Ambient Temperature 15℃~30℃, Temperature Uniformity ±2℃
Relative Humidity 20%~80%
Atmospheric Pressure 86 kPa~106 kPa
Operational Mode Average running time (min) Max.Flux (Sample/Day) Capillary Length(cm) Polymer type Continuous Reading Length (CRL)（CRL）
Sequence36_SY07 35 656 36 SY07 500 bp
Sequence50_SY07 120 192 50 SY07 850 bp
Fastseq50_SY07 60 384 50 SY07 700 bp
Operational Mode Average running time (min) Max.Flux (Sample/Day) Capillary Length(cm) Polymer type Continuous Reading Length (CRL)50-400    401-640    640-1200
GeneScan36_SY04 50 448 36 SY04 40-640 bp 640 bp <0.15 <0.3 N/A
GeneScan36_SY07 35 656 36 SY07 40-640 bp 640 bp <0.15 <0.3 N/A
GeneScan50_SY07 45 512 50 SY07 40-640 bp 640 bp <0.15 <0.3 N/A
GeneScan50_SY07Long 125 176 50 SY07 40-1200 bp 1200 bp <0.15 <0.3 <0.35
Consumable Reagent
Consumable Reagent Specification Model Unit Code
16-Channel Capillary tube 36 cm set SY01C001
16-Channel Capillary Capillary Array 50 cm set SY01C002
10x buffer 500 ml Bottle SY01C010
HD formamide 25 ml Bottle SY01C008
SY04 Polymer 3.5 ml Bottle SY01C005
SY07 Polymer 28 ml Bottle SY01C006
Product Application
Diseases/Drugs Detection Items Clinical Significance
Clopidogrel CYP2C19 Guarantee the safety and effectiveness of Clopidogrel
Aspirin COX1、GP1BA、LTC4S Evaluation of the resistance risk of Aspirin
Warfarin CYP2C9、VKORC1 Guidance of the usage measurement of Warfarin
Five types of Antihypertensive ADRB1、CYP2D6、NPPA、CYP3A5、CYP3A4、ACE、CYP2C9 Rational use of antihypertensive drugs
Statins SLCO1B1、ApoE Individualized treatment in accordance with the genetype
Nitroglycerin ALDH2 The instruction of using Nitroglycerin
Homocyste ine MTHFR High homocysteine levels are associated with a higher risk of cardiovascular disease
Diseases/Drugs Detection Items Clinical Significance
Hepatitis C Genotyping of hepatitis C virus Determine the illness,Assist in determining treatment options
Hepatitis B Hepatitis B virus drug resistance gene Guidance of using medicine for Hepatitis B
Tuberculosis (TB) Isoniazid resistance gene of Mycobacterium tuberculosis Guidance of using Medicine for clinic
Tuberculosis (TB) Mycobacterium tuberculosis is resistant to rifampicin Guidance of using Medicine for clinic
Human papillomavirus infection HPV genotyping Early detection of HPV infection
Multiple respiratory infections Common a variety of respiratory tract infection, respiratory tract bacteria, virus detection Auxiliary diagnosis and differential diagnosis of respiratory tract infection
HIV/AIDS Detection of drug resistance genotypes of human immunodeficiency virus type 1 (HIV-1) Guidance for medicine using resistance
Diseases/Drugs Detection Items Clinical Significance
Glioma IDH1, IDH2, TERT gene Classification and prognosis of glioma
Non-brainstem glioma/giant cell tumor of bone H3F3A, H3F3B genes Assist in the diagnosis of non-brainstem glioma and giant cell tumor of bone
Gastrointestinal stromal tumor KIT gene, PDGFRa gene Efficacy of tyrosine kinase inhibitors. Prognostic assessment of disease
Breast cance HER2, PIK3CA, CYP2D6, BRCA1/2 genes Prediction of disease risk, prognosis and effective treatment plan
Non-small cell lung cancer EGFR, K-RAS, B-Raf genes Predicting the efficacy of targeted drugs; Prognostic evaluation of disease
Colorectal cance K-ras, B-Raf, n-Ras genes Prognosis evaluation and medication guidance
Targeted drugs/sorafenib, sunitinib, pazopani, bevacizumab, erlotinib, etc PDGFRβ, VEGFR1, VEGFR2, EGFR, K-ras, B-Raf, PIK3CA, TTF-1, KIT, etc Guidance for using targeted medicine
Chemotherapy drugs/platinum, taxus, fluorine, gemcitabine, purine, etoposide, teniposide, etc ERCC1, ABCC2, XRCC1, GSTM1, XPD, GSTT1, GSTP1, BRCA1, etc. Predict drug efficacy and reduce toxic and side effects
Irinotecan UGT1A1 gene Predict drug efficacy and reduce toxic and side effects
Diseases/Drugs Detection Items Clinical Significance
Trisomy 21 syndrome, Klinefelter syndrome, superfemale syndrome Chromosome (13/18/21/X/Y) multiple STR genotyping Prenatal and prenatal auxiliary diagnosis
Duchenne muscular dystrophy DMD gene exon deletion, and repeat mutation detection Differential diagnosis, prenatal screening
Brittle syndrome Fragile X syndrome high-risk gene screening Diagnosis and establishment of diagnosis, prenatal screening
Spinal muscular atrophy Mutation detection of SMN1 and SMN2 genes Prenatal genetic screening
Phenylketonuria Detection of phenylketonuria gene mutation Confirming diagnosis and directing treatment; eugenics
Deafness Genetic testing for hereditary deafness Genetic screening for neonatal deafness
Anemia Detection of missing type α/β thalassemia (MLPA) The differential diagnosis
Wilson’s disease ATP7B gene Etiological diagnosis and early treatment; eugenics
Diseases/Drugs Detection Items Clinical Significance
Adolescent onset of adult type diabetes GCK, HNF1A, HNF4A, HNF1B, PDX1, NEUROD1 genes Differential diagnosis of diabetes type and guidance of using medicine
Susceptibility to type 1 diabetes MHC, CTLA4, TSHR genes The great significant to evaluate the risk of GD
Papillary thyroid carcinoma, medullary thyroid carcinoma RET gene RET gene mutation is the molecular pathological basis of MTC
Multiple endocrine neoplasm MEN1, RET gene Prenatal diagnosis and provide the risk evaluation
Abnormal lipid metabolism LDLR, APOB, LPL, ApoC ⅱ, ABCA1, ApoC ⅰ, ApoC ⅲ, ApoC ⅳ, ApoC ⅴ genes Effective screening of carriers, auxiliary diagnosis, early treatment
Diabetes OCT2、CYP2C9、PPARγ、SLCO1B1 Personalized guidance of using medication
Congenital adrenal hyperplasia CYP21A2 gene Auxiliary diagnosis
Hyperuricemia, gout HLA-B 5801 NCCN guidelines recommend hLA-B 5801 gene testing before allopurinol
Diseases/Drugs Detection Items Clinical Significance
Primary test for acute myeloid leukemia (AML) FLT3, KIT, TP53, RUNX1, CEBPA, ASXL1, NPM1, IDH1, IDH2 genes Assist in diagnosis, medication guidance and prognosis assessment
Primary test for acute myeloid leukemia (AML) DNMT3A, SF3B1, U2AF1, SRSF2, EZH2, WT1 genes Assist in diagnosis, prediction of disease progression and prognosis assessment
Acute lymphoblastic leukemia (ALL) BCR/ABL1, CRLF2, IKZF1, PRPS1, SH2B3, IL7R genes Assist in diagnosis, prediction of disease progression and prognosis assessment
Primary myelofibrosis (PMF) JAK2, MPL, ASXL1, EZH2, IDH1, IDH2, SRSF2, U2AF1, TP53 genes Assist in diagnosis and condition evaluation
Polycythemia vera (PV) JAK2, ASXL1, IDH1, IDH2, SRSF2 genes Assist in diagnosis and prognosis
Primary thrombocytopenia (ET) CALR、MPL、ASXL1、EZH2、SRSF2、U2AF1、TP53、SF3B1 genes Assist in diagnosis, prognosis and progression
Myelodysplastic syndrome (MDS) DNMT3A, ASXL1, EZH2, SF3B1, SRSF2, U2AF1, TP53, NRAS genes Assist in diagnosis, prognosis and progression
Lymphocytic lymphoma/Fahrenheit macroglobulinemia (LPL/WM) MYD88, CXCR4 gene Auxiliary diagnostic LPL/WM
Chronic neutrophil leukemia (CNL) CSF3R gene Deterministic molecular abnormalities of CNL and atypical CML
Diseases/Drugs Detection Items Clinical Significance
Parkinson’s disease. 11 Parkinson’s disease genes including SNCA Genetic screening and early diagnosis of Parkinson’s disease
Depression CYP2D6 and four other genes Guidance on antidepressant medication
Epilepsy POLG and four other genes Guidance of antiepileptic drugs
Mania Two loci on GSK3B and NTRK2 genes associated with antimanic drugs Guidance of using medicine for mania
Meningitis/encephalitis Simultaneous detection of multiple encephalitis and meningitis pathogens Etiological diagnosis of encephalitis and meningitis
Mental illness SLC6A2 and 6 other genes Guidance of using medicine for antipsychotic medication